Quantitative Assessment of Orofacial Muscle Function in FSHD

Development of a New Clinical Tool for the Assessment of Orofacial Muscles in Patients Affected by Facioscapulohumeral Muscular Dystrophy: a Preliminary Study.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06425445

Enrollment

Registered

2024-05-22

Start date

2024-05-14

Completion date

2025-01-31

Last updated

2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facioscapulohumeral Muscular Dystrophy

Brief summary

The goal of this study is to validate a new method for the assessment of orofacial muscles in FSHD affected individuals

Interventions

PROCEDUREOrofacial function assessment tests

Participants undergo serial measurements for the assessment of orofacial function

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

15 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Genetic diagnosis of FSHD type 1 and/or type 2

Exclusion criteria

* Pregnant women * Presence of other associated neuromuscular conditions * Any unstable interfering clinical situation

Design outcomes

Primary

Measure	Time frame
A performance index based on serial assessments of each participant	Measurements will be performed for each study participant at visit 1 and subsequently at visit 2 (3 months later). The measurements as such, should take about 30 minutes for each participant

Countries

Belgium

Contacts

PRINCIPAL_INVESTIGATORAlexandre Legrand (PhD, MD, principal investigator)

University of Mons

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026